By expenditures
| Name | Title | Type |
|---|---|---|
| Gabriel Morales-Burgos | Assistant Vice President for Financial Administration/Controller | Auditee |
| Jennifer Bird | PARTNER | Auditee |
| Carlos Charnichart | VICE PRESIDENT FINANCE | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 348681 | 2024 | 2025-03-26 | Gilliam Wharram & CO PC | $7.84M |
| 304813 | 2023 | 2024-04-28 | Gilliam Wharram & CO PC | $7.72M |
| 65445 | 2022 | 2023-03-30 | Gilliam Wharram & CO PC | $8.45M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 348681 | 2024 | 2025-03-26 | 1113918 | 2024-003 | Material Weakness | - | N |
| 348681 | 2024 | 2025-03-26 | 1113917 | 2024-003 | Material Weakness | - | N |
| 348681 | 2024 | 2025-03-26 | 1113916 | 2024-003 | Material Weakness | - | N |
| 348681 | 2024 | 2025-03-26 | 1113915 | 2024-002 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 1113914 | 2024-002 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 1113913 | 2024-001 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 1113912 | 2024-001 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 1113911 | 2024-002 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 537476 | 2024-003 | Material Weakness | - | N |
| 348681 | 2024 | 2025-03-26 | 537475 | 2024-003 | Material Weakness | - | N |
| 348681 | 2024 | 2025-03-26 | 537474 | 2024-003 | Material Weakness | - | N |
| 348681 | 2024 | 2025-03-26 | 537473 | 2024-002 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 537472 | 2024-002 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 537471 | 2024-001 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 537470 | 2024-001 | - | - | N |
| 348681 | 2024 | 2025-03-26 | 537469 | 2024-002 | - | - | N |
| 304813 | 2023 | 2024-04-28 | 971396 | 2023-005 | Material Weakness | - | B |
| 304813 | 2023 | 2024-04-28 | 971395 | 2023-005 | Material Weakness | - | B |
| 304813 | 2023 | 2024-04-28 | 971394 | 2023-003 | - | - | I |
| 304813 | 2023 | 2024-04-28 | 971393 | 2023-002 | - | - | B |
| 304813 | 2023 | 2024-04-28 | 971392 | 2023-002 | - | - | B |
| 304813 | 2023 | 2024-04-28 | 971391 | 2023-004 | - | - | N |
| 304813 | 2023 | 2024-04-28 | 971390 | 2023-004 | - | - | N |
| 304813 | 2023 | 2024-04-28 | 971389 | 2023-004 | - | - | N |
| 304813 | 2023 | 2024-04-28 | 971388 | 2023-004 | - | - | N |
| 304813 | 2023 | 2024-04-28 | 394954 | 2023-005 | Material Weakness | - | B |
| 304813 | 2023 | 2024-04-28 | 394953 | 2023-005 | Material Weakness | - | B |
| 304813 | 2023 | 2024-04-28 | 394952 | 2023-003 | - | - | I |
| 304813 | 2023 | 2024-04-28 | 394951 | 2023-002 | - | - | B |
| 304813 | 2023 | 2024-04-28 | 394950 | 2023-002 | - | - | B |
| 304813 | 2023 | 2024-04-28 | 394949 | 2023-004 | - | - | N |
| 304813 | 2023 | 2024-04-28 | 394948 | 2023-004 | - | - | N |
| 304813 | 2023 | 2024-04-28 | 394947 | 2023-004 | - | - | N |
| 304813 | 2023 | 2024-04-28 | 394946 | 2023-004 | - | - | N |
| 65445 | 2022 | 2023-03-30 | 648102 | 2022-001 | - | Yes | L |
| 65445 | 2022 | 2023-03-30 | 648101 | 2022-001 | - | Yes | L |
| 65445 | 2022 | 2023-03-30 | 648100 | 2022-001 | - | Yes | L |
| 65445 | 2022 | 2023-03-30 | 648099 | 2022-002 | - | - | E |
| 65445 | 2022 | 2023-03-30 | 648098 | 2022-003 | Significant Deficiency | - | E |
| 65445 | 2022 | 2023-03-30 | 648097 | 2022-003 | Significant Deficiency | - | E |
| 65445 | 2022 | 2023-03-30 | 648096 | 2022-003 | Significant Deficiency | - | E |
| 65445 | 2022 | 2023-03-30 | 648095 | 2022-003 | Significant Deficiency | - | E |
| 65445 | 2022 | 2023-03-30 | 71660 | 2022-001 | - | Yes | L |
| 65445 | 2022 | 2023-03-30 | 71659 | 2022-001 | - | Yes | L |
| 65445 | 2022 | 2023-03-30 | 71658 | 2022-001 | - | Yes | L |
| 65445 | 2022 | 2023-03-30 | 71657 | 2022-002 | - | - | E |
| 65445 | 2022 | 2023-03-30 | 71656 | 2022-003 | Significant Deficiency | - | E |
| 65445 | 2022 | 2023-03-30 | 71655 | 2022-003 | Significant Deficiency | - | E |
| 65445 | 2022 | 2023-03-30 | 71654 | 2022-003 | Significant Deficiency | - | E |
| 65445 | 2022 | 2023-03-30 | 71653 | 2022-003 | Significant Deficiency | - | E |